https://www.has-sante.fr/jcms/p_3497038/fr/optiray-ioversol-produit-de-contraste-iode 2024 false false false France ioversol evaluation of the transparency committee iodine ioversol contrast media
--- https://ansm.sante.fr/informations-de-securite/kits-optiject-risque-de-fissure-au-niveau-de-la-connexion-entre-la-seringue-et-la-tubulure-dinjection-de-produit-de-contraste 2023 false false false France French pharmacovigilance note contrast media risk Device cracked ioversol ioversol
--- https://www.has-sante.fr/jcms/p_3289347/fr/optiray-ioversol 2021 false false false France contrast media ioversol evaluation of the transparency committee ioversol
--- https://www.has-sante.fr/jcms/p_3117096/fr/optiject 2019 false false false France evaluation of the transparency committee ioversol ioversol
--- https://www.has-sante.fr/portail/jcms/c_2894903/en/optiject-optiray 2018 false true false France insurance, health, reimbursement ioversol Outcome Assessment, Health Care contrast media injections evaluation of the transparency committee ioversol triiodobenzoic acids
--- http://www.has-sante.fr/portail/jcms/c_1621545/fr/optiray-optiject http://www.has-sante.fr/portail/jcms/c_1621543/fr/optiray-optiject-15052013-avis-ct11812 http://www.has-sante.fr/portail/display.jsp?id=c_474462 2013 false France French evaluation of the transparency committee ioversol injections Outcome Assessment, Health Care insurance, health, reimbursement ioversol contrast media triiodobenzoic acids
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62823503 2012 France summary of product characteristics package leaflet ioversol injections
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67470459 2012 France summary of product characteristics package leaflet injections ioversol
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69078599 2012 France summary of product characteristics package leaflet injections ioversol